Prospective Study Evaluating Dry Eye in Patients Operated on for Ametropia by LASIK Surgery and Treated With REPADROP (PREPADROP)

Civil Hospices of Lyon

Status: Completed

Conditions: Ametropia

Treatments: Other: Describe the evolution of dry eye between 1 month and 3 months post-LASIK

Study type: Observational

Funder types: Other

Identifiers

NCT04654455

69HCL20_1049

Details and patient eligibility

About

LASIK is a refractive surgery technique widely used in France. Postoperatively, the classic treatment after LASIK consists of instilling drops to reduce dry eyes. REPADROP® is an innovative eye drops stimulating corneal innervation. To date no study has quantified the improvement in dry eye syndrome and thus the quality of life of patients using REPADROP®.

Enrollment: 10 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Age over 18

• Planned bilateral LASIK surgery
• Use of Repadrop as postoperative eye drops
• Patient agreement to participate

Exclusion criteria

• History of corneal pathology
• Diabetes
• History of treatment with REPADROP® or CACICOL® or NGF® (other eye drops which are no longer available on the market to date but which would also improve corneal healing)
• Ongoing treatment with topical cyclosporine
• Presence of punctal plugs
• Adults who are the subject of a legal protection measure (guardianship, curators)
• Pregnant or breastfeeding women